• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$72.67 -$0.09 (-0.12%)

REAL-TIME: Last trade at

Watson Pharmaceuticals, Inc.

NYSE:WPI

Watson to Present at the Jefferies 2012 Global Healthcare Conference

Watson Confirms Testim® Patent Challenge

Duke Energy, Watson Pharma: Overlooked M&A Stocks

Wells Fargo Upgrades Watson Pharmaceuticals (WPI) to Outperform; Actavis Acquisition Adds Growth Prospects

Watson upgraded to Outperform from Market Perform at Wells Fargo

WCRX, Watson Pharma in Legal Tussle - Analyst Blog

WCRX, Watson Pharma in Legal Tussle

Canaccord Genuity Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); Recent Visit Confirms 'Top Idea' Thesis

Top Analyst Upgrades & Downgrades (ABMD, MT, BXP, DPZ, DRYS, FET, GPS, BLOX, LYB, OAK, POOL, SNTA, TSLA, URBN, WPI, ZIP)

Elementary, My Dear Watson Pharmaceuticals

Elementary, My Dear Watson Pharmaceuticals

Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference

Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference

Warner Chilcott, PLC Sues Watson Pharmaceuticals, Inc. Over Generic Contraceptive

The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft

Watson Confirms Lo Loestrin® Fe Patent Challenge

The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft - Press Releases

Watson and Shire in Legal Battle - Analyst Blog

Watson and Shire in Legal Battle - Analyst Blog

Watson and Shire in Legal Battle

Watson Pharmaceuticals remains a Top Pick at Buckingham

Watson Pharmaceuticals, Inc. Shuts Down Groveport Warehouse, Lays Off 55

Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Increased Sales Driving Generic Drug Makers Higher

Watson Pharmaceuticals Pulls Back After Bullish Gap

Watson Pharmaceuticals closing Groveport warehouse, costing 55 jobs

Watson Confirms Lialda Patent Challenge

Watson Pharmaceuticals confirms Lialda patent challenge

Watson Confirms Lialda® Patent Challenge

Watson Announces Formation of Global Integration Management Office to Support Pending Actavis Acquisition

Watson Pharma (WPI) Forms Global Integration Manangement Office to Support Actavis Purchase

Watson Announces Formation of Global Integration Management Office to Support Pending Actavis Acquisition

Watson Names Lisa DeFrancesco Vice President, Global Investor Relations

Watson Pharmaceuticals target raised to $88 from $78 at Argus

Second Look: Is There Any Real Value Left In Savient? (SVNT, DNDN, SVNT)

Watson Pharmaceuticals can still deliver potent returns, Barron's says

24/7 Wall St. Closing Bell (WPI, AZN, ANF, SPWR, YGE, COST, MERU, ACI, VECO, PBY, ADM, CPO, AVP, DPZ, PFE, VLO, ABX, JDSU, MRO, FSLR, V, PFCB, DAL, CHK)

RBC Capital Lifts PT On Watson Pharmaceuticals (WPI) To $85 For Actavis Acquisition

Canaccord Genuity Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); Standalone Story Intact

Watson Pharmaceuticals To Webcast Annual Meeting Of Stockholders On May 11, 2012

Watson Pharmaceuticals To Webcast Annual Meeting Of Stockholders On May 11, 2012

See More Articles...